文献速递产科

剖宫产加速康复路径改善结局

Improved Outcomes With an Enhanced Recovery Approach to Cesarean Delivery.
PubMed 文献 · Obstet Gynecol · 2020-01-01

该质量改进研究采用前后对照设计,评估2018年12月实施基于循证的剖宫产加速康复外科(ERAS)路径前后阿片类药物使用、住院时间和费用的变化。共纳入3679例剖宫产,实施前2171例、实施后1508例;实施后住院患者阿片类药物使用比例由84%降至24%(OR 16.8,95%CI 14.3-19.9),住院时间缩短(3.2 vs 2.7天),直接费用中位数降低349美元,30天再入院率无变化(1.4% vs 1.7%,OR 0.83,95%CI 0.49-1.41)。

要点

  • 实施ERAS路径后,剖宫产住院患者阿片类药物使用比例由84%降至24%(OR 16.8,95%CI 14.3-19.9)。
  • 实施ERAS路径后,剖宫产术后住院时间由3.2天缩短至2.7天(平均相对变化0.82,95%CI 0.80-0.83)。
  • 实施ERAS路径后,直接费用中位数降低349美元,30天再入院率无显著变化(1.4% vs 1.7%,OR 0.83,95%CI 0.49-1.41)。

核心结论

  • 剖宫产人群采用ERAS路径与结局改善相关,包括阿片类药物使用减少、住院时间缩短和费用降低。

研究设计与样本

  • 质量改进研究,采用前后对照设计,评估2018年12月起实施的基于循证的剖宫产ERAS路径(涵盖术前、术中、术后管理)前后阿片类药物使用、住院时间和费用的变化。
  • 共纳入2018年1月1日至2019年8月31日期间3679例剖宫产(择期和急诊),其中2018年12月17日实施前2171例,实施后1508例。

主要发现

  • 实施前84%的患者剖宫产后住院期间使用阿片类药物,实施后为24%(OR 16.8,95%CI 14.3-19.9)。
  • 在需要使用阿片类药物的患者中,总吗啡毫克当量中位数由56.5降至15.0(平均相对变化0.32,95%CI 0.28-0.35)。
  • 与实施前相比,实施后剖宫产术后住院时间缩短(3.2 vs 2.7天,平均相对变化0.82,95%CI 0.80-0.83,两时期中位数均为3天)。
  • 实施后直接费用中位数降低349美元(平均相对变化0.93,95%CI 0.91-0.95)。
  • 30天再入院率无变化(1.4% vs 1.7%,OR 0.83,95%CI 0.49-1.41)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the results of a quality-improvement study that implemented an enhanced recovery after surgery (ERAS) program for cesarean delivery. METHODS: A pre-post design was used to assess changes in opioid use, length of stay, and costs among all patients undergoing cesarean delivery before and after implementation of an evidence-based ERAS pathway for the preoperative, intraoperative, and postoperative management of patients beginning December 2018. RESULTS: A total of 3,679 cesarean deliveries (scheduled and emergent) were included from January 1, 2018, through August 31, 2019, of which 2,171 occurred before implementation on December 17, 2018, and 1,508 occurred postimplementation. Eighty-four percent of patients received opioids as inpatients after cesarean delivery during the preimplementation period, as compared with 24% in the postimplementation period (odds ratio [OR] 16.8, 95% CI 14.3-19.9). Among patients who required any opioids, the total morphine milligram equivalents also significantly decreased (median 56.5 vs 15.0, mean relative change 0.32, 95% CI 0.28-0.35). Compared with the preimplementation period, those in the postimplementation period had a shorter postcesarean length of stay (3.2 vs 2.7 days, mean relative change 0.82, 95% CI 0.80-0.83, median 3 days in both periods), lower median direct costs by $349 (mean relative change 0.93, 95% CI 0.91-0.95), and no change in the 30-day readmission rate (1.4% vs 1.7%, OR 0.83, 95% CI 0.49-1.41). CONCLUSION: An ERAS approach for the cesarean delivery population is associated with improved outcomes including decreases in opioid use, length of stay, and costs.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Mullman L, Hilden P, Goral J, et al. Improved Outcomes With an Enhanced Recovery Approach to Cesarean Delivery. Obstet Gynecol. 2020. PMID: 32925620. doi:10.1097/AOG.0000000000004023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。